Menu Search
Equities

Nanologica AB (publ)

  • Add to watchlist
  • Add to portfolio
  • Add an alert
4YD:FRA

Nanologica AB (publ)

Actions
  • Price (EUR)0.035
  • Today's Change0.00 / 0.00%
  • Shares traded20.00k
  • 1 Year change-77.64%
  • Beta0.5509
Data delayed at least 15 minutes, as of Feb 12 2026 07:05 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Nanologica AB (publ) is a Sweden-based materials development company. The Company specializes in developing nanoporous materials from nanoporous silica (silicon dioxide) for a variety of applications, ranging from purification to pharmaceutical excipients. The Company's core competency has been developed and expanded in two areas of application, in particular: Drug Delivery and Chromatography, a technology used for the separation and purification of products on the market and in development. The Company's Drug Delivery sector operates within a niche domain of nanocarriers. Nanologica AB (publ)’s drug delivery technology is aimed on absorption of the medicine by the body for drugs that are poorly soluble in water.

  • Revenue in SEK (TTM)22.65m
  • Net income in SEK-47.51m
  • Incorporated2004
  • Employees19.00
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		NICA:STO since
announced		Transaction
value
Ardena Sodertalje ABDeal completed29 Jan 202629 Jan 2026Deal completed-28.77%974.00k
Data delayed at least 15 minutes, as of Feb 12 2026 12:38 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.